Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 5, 2016Experience the Difference of Enterprise-wide Medication Management at #ASHP16 Midyear Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will demonstrate an enhanced technology platform designed with the ability to synchronize BD medication...
-
Dec 1, 2016New Operating System Offers Health Systems Long-Term Medication Management Platform and Enhanced Cybersecurity
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced adoption of Windows 10 Internet of Things (IoT) operating system (OS) for its...
-
Nov 17, 2016
Franklin Lakes, NJ (November 14, 2016) - BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will host an institutional investor and analyst meeting on Thursday, November 17,...
-
Nov 17, 2016
Earnings Releases / Presentations About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery,...
-
Nov 10, 2016BD to Showcase Latest Advancements at the 16th Annual Diabetes Technology Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company today announced a new research collaboration supported by JDRF, the leading global organization funding...
-
Nov 8, 2016BD and Lilly Diabetes Collaboration Offers New Delivery Solution for People with Insulin Resistance
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company announced today the launch of the BD(TM) U-500 Insulin Syringe, the first insulin syringe developed for...
-
Nov 3, 2016
Click on the links below to view results for 2016 Third Fiscal Quarter: View document online » PDF File of BD 2016 Third Fiscal Quarter Results » About BD BD is one of the largest global medical...
-
Oct 31, 2016Expands Reproductive and Sexually Transmitted Infections Portfolio with First Test Using Microbiome-based Algorithm for Bacterial Vaginosis Detection
FRANKLIN LAKES, N.J., Oct. 31, 2016 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) market...
-
Oct 4, 2016Apax Funds to be majority owner of new company, Vyaire Medical
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Apax Partners, today announced the launch of a joint venture - Vyaire Medical - a standalone,...
-
Sep 30, 2016New BD Phoenix(TM) M50 System delivers modularity, reliability, affordability and high-quality susceptibility results needed by clinical microbiology laboratories worldwide
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of its next generation diagnostic instrument for the rapid identification of...
-
Sep 29, 2016The New BD Vacutainer® Barricor(TM) Tube Offers First Major Advance in Plasma Separation Technology in Decades
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for the BD Vacutainer(®)...
-
Sep 22, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it is investing $100 million in its Holdrege, Neb. facility to expand capacity for its...
-
Sep 21, 2016New BD Veritor(TM) Plus System Enables Fast and Accurate Test Results for Health Care Providers
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of its next generation wireless rapid diagnostic system for detection of...
-
Sep 16, 2016BD ChloraShield(TM) Dressings are Now Available for a Range of Vascular Access Procedures
BD (Becton, Dickinson and Company) (NYSE: BDX) and Vancive Medical Technologies(TM), an Avery Dennison (NYSE: AVY) business, today launched a line of transparent vascular dressings with...
-
Sep 13, 2016BD Obtains FDA Clearance for the BD MAX CT/GC/TV Assay on the BD MAX™ System
FRANKLIN LAKES, N.J., Sept. 13, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it obtained U.S. Food and Drug...
-
Sep 12, 2016Latest Release of Industry-Leading Pyxis ES platform Advances Enterprise-wide Medication Management and Patient Safety Across Continuum of Care
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced general availability of the latest software release of Pyxis(TM) ES System, delivering...
-
Sep 6, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has submitted a pre-market approval (PMA) application to the U.S. Food and Drug...
-
Sep 1, 2016New Recommendations Based on Findings from Largest-Ever International Survey of more than 13,200 Insulin-Injecting Patients from 42 Countries
The prestigious medical journal, Mayo Clinic Proceedings , today published new insulin delivery recommendations for health care professionals caring for insulin-using patients, including the...
-
Aug 18, 2016Announces $20 Million Investment to Support Growth
SANDY, Utah, Aug. 18, 2016 /PRNewswire/ – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was joined by senior public officials today to celebrate...
-
Aug 16, 2016Alaris(TM) System Also Cited as Most Comprehensive Infusion Platform
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its Alaris(TM) System infusion platform was cited as having the most customers...
-
Aug 15, 2016
FRANKLIN LAKES, N.J., August 15, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug...
-
Aug 4, 2016
Click on the links below to view results for 2016 Third Fiscal Quarter: View document online » PDF File of BD 2016 Third Fiscal Quarter Results » About BD BD is one of the largest global medical...
-
Jul 28, 2016
FRANKLIN LAKES, N.J., JULY 26, 2016 – The Board of Directors BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 66 cents per common share, payable on September...
-
Jul 28, 2016
FRANKLIN LAKES, N.J., JULY 28, 2016 – BD(Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that R. Andrew “Andy” Eckert has been...
-
Jul 19, 2016More than 100 Hospitals Have Implemented Interoperability for Alaris(TM) System
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that more than 100 hospitals and health systems have implemented the company's...